Mitochondrial Iron Metabolism: The Crucial Actors in Diseases
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Iron is a trace element necessary for cell growth, development, and cellular homeostasis, but insufficient or excessive level of iron is toxic. Intracellularly, sufficient amounts of iron are required for mitochondria (the center of iron utilization) to maintain their normal physiologic function. Iron deficiency impairs mitochondrial metabolism and respiratory activity, while mitochondrial iron overload promotes ROS production during mitochondrial electron transport, thus promoting potential disease development. This review provides an overview of iron homeostasis, mitochondrial iron metabolism, and how mitochondrial iron imbalances-induced mitochondrial dysfunction contribute to diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667 · cited 1×
“To guard dissociative iron against oxidative damage to cells, excess cellular iron is stored in ferritin [21].”
BackgroundThe role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381 · cited 1×
“Notably, the cellular redox equilibrium can be easily disrupted by catalytic amounts of iron, thus resulting in the generation of toxic reactive oxygen species (ROS) and oxidative stress [2,3].”
BackgroundAndrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130 · cited 2×
“by the tight control of dietary absorption in the duodenum [11, 12].”
BackgroundTwo to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 1×
“The opposite effect occurs when cellular iron levels are high [28].”
BackgroundFerric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083 · cited 1×
“Heart failure symptoms in the patient population can be improved by intravenous iron supplementation, which has been a recommended treatment for patients with heart failure with iron deficiency [79,80].”
BackgroundPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · cited 14×
“Concerning the mechanism for iron overload-induced ferroptosis, recent studies using a model of aristolactam I-induced ferroptosis reported that Fe2+ overload-mediated mitochondrial ROS over-release would activate lipid peroxidation and inhibit the antioxidant system Molecules 2023, 28, 29 8 of 18 by inhibiting nuclea…”
BackgroundInfluentialThe iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275
Synchronized renal tubular cell death involves ferroptosis
Linkermann, A., Skouta, R., Himmerkus, N., Mulay, S. R., Dewitz, C., De Zen, F., Prokai, A., Zuchtriegel, G., Krombach, F., Welz, P.-S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415518111 · Cited by 1,126
An iron-regulated ferric reductase associated with the absorption of dietary iron
McKie, A. T., Barrow, D., Latunde-Dada, G. O., Rolfs, A., Sager, G., Mudaly, E., Mudaly, M., Richardson, C., Barlow, D., Bomford, A., et al. (2001) · Science · doi:10.1126/science.1057206 · Cited by 1,101
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070 · cited 2×
“In the presence of physiological pH and oxygen, dietary iron mainly exists in the form of highly insoluble iron Fe (III), while the iron transport system absorbs ferrous Fe (II) ions, which are very unstable and rapidly oxidized to trivalent iron [9,10].”
BackgroundThe role of iron regulatory proteins in mammalian iron homeostasis and disease
Rouault, T. A. (2006) · Nature Chemical Biology · doi:10.1038/nchembio807 · Cited by 1,055 · cited 1×
“In response to alterations in the levels of intracellular iron, this system can regulate the expression of post-translational ferritin and transferrin receptors and alter the synthesis of pivotal iron metabolic proteins [26,27].”
BackgroundRegulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986 · cited 2×
“by the tight control of dietary absorption in the duodenum [11, 12].”
BackgroundPuccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738 · cited 1×
“Recent work in patients [63] and in mouse models [64,65] provides evidence that this disease is characterized by significant accumulation of iron inside the mitochondria, extensive mitochondrial dysfunction, and oxidative damage [42,66].”
BackgroundIron deficiency in chronic heart failure: an international pooled analysis
Klip, I. T., Comin-Colet, J., Voors, A. A., Ponikowski, P., Enjuanes, C., Banasiak, W., Lok, D. J., Rosentryt, P., Torrens, A., Polonski, L., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.017 · Cited by 736 · cited 1×
“There is validation that iron deficiency is present in approximately 30%~50% of patients with chronic heart failure [78].”
BackgroundCross-Talk Between Iron Metabolism and Diabetes
Fernández-Real, J. M., López-Bermejo, A., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2348 · Cited by 704
Muckenthaler, M. U., Galy, B., & Hentze, M. W. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155521 · Cited by 701
Mitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688 · cited 1×
“It has been reported that mitochondrial dysfunction is a common pathogenic feature of NDDs such as AD and PD [135,136].”
BackgroundFulster, S., Tacke, M., Sandek, A., Ebner, N., Tschope, C., Doehner, W., Anker, S. D., & von Haehling, S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs381 · Cited by 658 · cited 1×
“Muscle atrophy, also called sarcopenia, is characterized by loss of skeletal muscle mass [86] and can be induced by aging [87] and various chronic diseases [88,89].”
BackgroundNon-transferrin bound iron: a key role in iron overload and iron toxicity
Brissot, P., Ropert, M., Le Lan, C., & Loréal, O. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.014 · Cited by 654 · cited 1×
“ROS production is also catalyzed by excess iron, which causes lipid peroxidation and organelle damage [62].”
BackgroundEvans, W. J. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.5 · Cited by 606
Mechanisms of mammalian iron homeostasis
Pantopoulos, K., Porwal, S. K., Tartakoff, A., & Devireddy, L. (2012) · Biochemistry · doi:10.1021/bi300752r · Cited by 598 · cited 8×
“Meanwhile, the expression of iron homeostasis proteins associated with iron accumulation is altered in multiple cancer cell types, such as an elevated expression of the iron uptake-related protein TFR1, a reduced expression of the iron export-related protein ferro- portin, and an elevated production of hepcidin.”
BackgroundInfluentialKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Iron and cancer: recent insights
Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13008 · Cited by 507 · cited 3×
“Iron chelators affect the initiation, growth, proliferation, and metastasis of cancer cells by targeting different stages of disease progression, including associated iron metabolic pathways and iron-containing proteins [160,173].”
BackgroundTorti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426
Body Iron Stores and the Risk of Carotid Atherosclerosis: Prospective Results From the Bruneck Study
Kiechl, S., Willeit, J., Egger, G., Poewe, W., & Oberhollenzer, F. (1997) · Circulation · doi:10.1161/01.cir.96.10.3300 · Cited by 390
Iron–sulfur cluster biogenesis and trafficking in mitochondria
Braymer, J. J., & Lill, R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.787101 · Cited by 389 · cited 5×
“The other one is that more iron may be imported to mitochondria of cancer cells during rapid cell proliferation, in order to produce heme and Fe-S cluster and to satisf i creasing demands for thes cofactors.”
BackgroundInfluentialIron-Sulfur Protein Biogenesis in Eukaryotes: Components and Mechanisms
Lill, R., & Mühlenhoff, U. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104538 · Cited by 365 · cited 1×
“Both of them facilitate oxidation-reduction reactions and are essential components of enzymes involved in electron transport [34,35].”
BackgroundOxidative Stress and Iron Homeostasis: Mechanistic and Health Aspects
Galaris, D., & Pantopoulos, K. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701713104 · Cited by 352 · cited 1×
“Notably, the cellular redox equilibrium can be easily disrupted by catalytic amounts of iron, thus resulting in the generation of toxic reactive oxygen species (ROS) and oxidative stress [2,3].”
BackgroundTargeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352 · cited 2×
“(DFO) [174, 175], which was originally used as a treatment for iron overload [176].”
BackgroundMethodHoes, M. F., Grote Beverborg, N., Kijlstra, J. D., Kuipers, J., Swinkels, D. W., Giepmans, B. N. G., Rodenburg, R. J., van Veldhuisen, D. J., de Boer, R. A., & van der Meer, P. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1154 · Cited by 333
Labile iron in cells and body fluids: Physiology, pathology, and pharmacology
Cabantchik, Z. I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00045 · Cited by 306
Dietary iron intake and risk of coronary disease among men.
Ascherio, A., Willett, W. C., Rimm, E. B., Giovannucci, E. L., & Stampfer, M. J. (1994) · Circulation · doi:10.1161/01.cir.89.3.969 · Cited by 286
Chung, J.-Y., Kang, H.-T., Lee, D.-C., Lee, H.-R., & Lee, Y.-J. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.09.007 · Cited by 283
Wasting in chronic kidney disease
Mak, R. H., Ikizler, A. T., Kovesdy, C. P., Raj, D. S., Stenvinkel, P., & Kalantar-Zadeh, K. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0019-5 · Cited by 281
Mastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195
Specific iron chelators determine the route of ferritin degradation
De Domenico, I., Ward, D. M., & Kaplan, J. (2009) · Blood · doi:10.1182/blood-2009-05-224188 · Cited by 176 · cited 2×
“It can also target ferritin through autophagy degradation [177].”
BackgroundMitochondrial death effectors: Relevance to sarcopenia and disuse muscle atrophy
Marzetti, E., Hwang, J. C. Y., Lees, H. A., Wohlgemuth, S. E., Dupont-Versteegden, E. E., Carter, C. S., Bernabei, R., & Leeuwenburgh, C. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.05.007 · Cited by 174
Pietrangelo, A. (2016) · Liver International · doi:10.1111/liv.13020 · Cited by 174
Ineffective erythropoiesis and regulation of iron status in iron loading anaemias
Camaschella, C., & Nai, A. (2016) · British Journal of Haematology · doi:10.1111/bjh.13820 · Cited by 172 · cited 2×
“When the iron storage and antioxidant capacity of the liver is exceeded, iron overload can lead to liver fibrosis, cirrhosis, and even hepatoma, as seen in β-thalassemia and hereditary hemochromatosis [43,81].”
BackgroundRedistribution of accumulated cell iron: a modality of chelation with therapeutic implications
Sohn, Y.-S., Breuer, W., Munnich, A., & Cabantchik, Z. I. (2008) · Blood · doi:10.1182/blood-2007-07-102335 · Cited by 167 · cited 1×
“iron chelator deferiprone and an antioxidant [68,69], supporting the role of mitochondrial iron in the pathophysiology of cardiac dysfunction.”
BackgroundIron regulatory proteins secure mitochondrial iron sufficiency and function
Galy, B., Ferring-Appel, D., Sauer, S. W., Kaden, S., Lyoumi, S., Puy, H., Kölker, S., Gröne, H.-J., & Hentze, M. W. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.007 · Cited by 147 · cited 1×
“Under oxidative stress, mitochondria (the cellular energy centers) are impaired, leading to impaired energy state and potential disease development [4,5].”
BackgroundIron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia
Michael, S., Petrocine, S. V., Qian, J., Lamarche, J. B., Knutson, M. D., Garrick, M. D., & Koeppen, A. H. (2006) · The Cerebellum · doi:10.1080/14734220600913246 · Cited by 122 · cited 1×
“Recent work in patients [63] and in mouse models [64,65] provides evidence that this disease is characterized by significant accumulation of iron inside the mitochondria, extensive mitochondrial dysfunction, and oxidative damage [42,66].”
BackgroundDietary haem iron and coronary heart disease in women
van der A, D. L., Peeters, P. H. M., Grobbee, D. E., Marx, J. J. M., & van der Schouw, Y. T. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi027 · Cited by 78
Aging-related changes in the iron status of skeletal muscle
DeRuisseau, K. C., Park, Y.-M., DeRuisseau, L. R., Cowley, P. M., Fazen, C. H., & Doyle, R. P. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.08.011 · Cited by 69 · cited 2×
“The adaptive downregulation in IRP2 results in a decreased expression of TFR1 (an iron transporter) and an increased expression of ferritin (an iron storage protein), which constitutes a proposed mechanism that may explain the accelerated iron accumulation in skeletal muscle of aged rats [44].”
BackgroundThe role of endocytic pathways in cellular uptake of plasma non-transferrin iron
Sohn, Y.-S., Ghoti, H., Breuer, W., Rachmilewitz, E., Attar, S., Weiss, G., & Cabantchik, Z. I. (2012) · Haematologica · doi:10.3324/haematol.2011.054858 · Cited by 44 · cited 1×
“Once plasma iron exceeds the carrying capacity of transferrin, iron and transferrin are not tightly bound to form non-transferrin-bound iron (NTBI), which is taken up by tissues (such as the heart, pancreas, and liver) through endocytosis [23], thus giving rise to tissue damage [24].”
BackgroundToyokuni, S., Kong, Y., Cheng, Z., Sato, K., Hayashi, S., Ito, F., Jiang, L., Yanatori, I., Okazaki, Y., & Akatsuka, S. (2020) · Cancers · doi:10.3390/cancers12113320 · Cited by 33
Horinouchi, Y., Ikeda, Y., & Tamaki, T. (2019) · Folia Pharmacologica Japonica · doi:10.1254/fpj.154.316 · Cited by 8 · cited 1×
“This toxic effect on β cells leads to defects in insulin synthesis and secretion [45,112,113].”
Background
Research works printed but not linked: 130
- Dev, 2017, Overview of iron metabolism in health and disease, Hemodial. Int., 21, S6, 10.1111/hdi.12542 · DOI · Paper page
- Swaminathan, 2018, Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury, Nephron, 140, 156, 10.1159/000490808 · DOI
- Gao, 2021, Mitochondrial iron metabolism and its role in diseases, Clin. Chim. Acta, 513, 6, 10.1016/j.cca.2020.12.005 · DOI
- Levi, 2009, The role of iron in mitochondrial function, Biochim. Biophys. Acta, 1790, 629, 10.1016/j.bbagen.2008.09.008 · DOI · Paper page
- Choi, 2012, Duodenal reductase activity and spleen iron stores are reduced and erythropoiesis is abnormal in Dcytb knockout mice exposed to hypoxic conditions, J. Nutr., 142, 1929, 10.3945/jn.112.160358 · DOI
- Muir, 1985, Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice, Am. J. Physiol., 248, G376
- Xue, 2016, Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis, Cell Metab., 24, 447, 10.1016/j.cmet.2016.07.015 · DOI · Paper page
- Theil, 2012, Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments, J. Nutr., 142, 478, 10.3945/jn.111.145854 · DOI
- Troadec, 2010, Induction of FPN1 transcription by MTF-1 reveals a role for ferroportin in transition metal efflux, Blood, 116, 4657, 10.1182/blood-2010-04-278614 · DOI · Paper page
- Strzyz, 2020, Iron expulsion by exosomes drives ferroptosis resistance, Nat. Rev. Mol. Cell Biol., 21, 4, 10.1038/s41580-019-0195-2 · DOI
- Wood, 2014, Guidelines for quantifying iron overload, Hematol. Am. Soc. Hematol. Educ. Program, 2014, 210, 10.1182/asheducation-2014.1.210 · DOI
- Li, 2020, Transferrin Receptor 1 Regulates Thermogenic Capacity and Cell Fate in Brown/Beige Adipocytes, Adv. Sci., 7, 1903366, 10.1002/advs.201903366 · DOI
- Rensvold, 2016, Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis, J. Biol. Chem., 291, 20827, 10.1074/jbc.M116.727701 · DOI
- Swenson, S.A., Moore, C.M., Marcero, J.R., Medlock, A.E., Reddi, A.R., and Khalimonchuk, O. (2020). From Synthesis to Utilization: The Ins and Outs of Mitochondrial Heme. Cells, 9. · DOI
- Pandey, 2019, Mitochondria export iron-sulfur and sulfur intermediates to the cytoplasm for iron-sulfur cluster assembly and tRNA thiolation in yeast, J. Biol. Chem., 294, 9489, 10.1074/jbc.RA119.008600 · DOI
- Zorov, 1997, Mitochondria revisited. Alternative functions of mitochondria, Biosci. Rep., 17, 507, 10.1023/A:1027304122259 · DOI
- Paul, 2017, Mitochondria and Iron: Current questions, Expert Rev. Hematol., 10, 65, 10.1080/17474086.2016.1268047 · DOI · Paper page
- Ward, 2019, Mitochondrial Iron in Human Health and Disease, Annu. Rev. Physiol., 81, 453, 10.1146/annurev-physiol-020518-114742 · DOI · Paper page
- Santambrogio, 2015, Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients, Neurobiol. Dis., 81, 144, 10.1016/j.nbd.2015.02.030 · DOI
- Tavsan, 2015, The Variations of Glycolysis and TCA Cycle Intermediate Levels Grown in Iron and Copper Mediums of Trichoderma harzianum, Appl. Biochem. Biotechnol., 176, 76, 10.1007/s12010-015-1535-0 · DOI
- Manceau, H., Ausseil, J., Masson, D., Feugeas, J.P., Sablonniere, B., Guieu, R., Puy, H., and Peoc’h, K. (2022). Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency. Nutrients, 14. · DOI
- Payne, 2011, The Heart in Friedreich’s Ataxia: Basic Findings and Clinical Implications, Prog. Pediatr. Cardiol., 31, 103, 10.1016/j.ppedcard.2011.02.007 · DOI
- Kusminski, 2020, A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive beta-Cell Hyperplasia, Diabetes, 69, 313, 10.2337/db19-0327 · DOI · Paper page
- Nankivell, 1992, Iron accumulation in human chronic renal disease, Am. J. Kidney Dis., 20, 580, 10.1016/S0272-6386(12)70222-6 · DOI
- Mezzaroba, 2019, The role of zinc, copper, manganese and iron in neurodegenerative diseases, Neurotoxicology, 74, 230, 10.1016/j.neuro.2019.07.007 · DOI · Paper page
- Mostile, 2017, Iron and Parkinson’s disease: A systematic review and meta-analysis, Mol. Med. Rep., 15, 3383, 10.3892/mmr.2017.6386 · DOI
- Bajbouj, 2017, Estrogen-induced disruption of intracellular iron metabolism leads to oxidative stress, membrane damage, and cell cycle arrest in MCF-7 cells, Tumour Biol., 39, 1010428317726184, 10.1177/1010428317726184 · DOI
- Chen, 2014, Cardiac mitochondria and reactive oxygen species generation, Circ. Res., 114, 524, 10.1161/CIRCRESAHA.114.300559 · DOI · Paper page
- Gammella, 2015, Iron-induced damage in cardiomyopathy: Oxidative-dependent and independent mechanisms, Oxid. Med. Cell. Longev., 2015, 230182, 10.1155/2015/230182 · DOI
- Melenovsky, 2017, Myocardial iron content and mitochondrial function in human heart failure: A direct tissue analysis, Eur. J. Heart Fail., 19, 522, 10.1002/ejhf.640 · DOI · Paper page
- Loncar, 2021, Iron deficiency in heart failure, ESC Heart Fail., 8, 2368, 10.1002/ehf2.13265 · DOI
- Ebner, 2019, Iron Deficiency in Heart Failure: An Overview, JACC Heart Fail., 7, 36, 10.1016/j.jchf.2018.07.015 · DOI · Paper page
- Chopra, 2020, Anaemia, iron deficiency and heart failure in 2020: Facts and numbers, ESC Heart Fail., 7, 2007, 10.1002/ehf2.12797 · DOI
- Rineau, 2018, Iron deficiency without anemia is responsible for decreased left ventricular function and reduced mitochondrial complex I activity in a mouse model, Int. J. Cardiol., 266, 206, 10.1016/j.ijcard.2018.02.021 · DOI
- Vinchi, 2020, Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction, Eur. Heart J., 41, 2681, 10.1093/eurheartj/ehz112 · DOI · Paper page
- Whitnall, 2008, The MCK mouse heart model of Friedreich’s ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation, Proc. Natl. Acad. Sci. USA, 105, 9757, 10.1073/pnas.0804261105 · DOI · Paper page
- Gao, 2010, Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload, Free Radic. Biol. Med., 49, 401, 10.1016/j.freeradbiomed.2010.04.033 · DOI
- Chang, 2016, Reduction in mitochondrial iron alleviates cardiac damage during injury, EMBO Mol. Med., 8, 247, 10.15252/emmm.201505748 · DOI · Paper page
- Aracil, 2011, Combined therapy with idebenone and deferiprone in patients with Friedreich’s ataxia, Cerebellum, 10, 1, 10.1007/s12311-010-0212-7 · DOI
- Ichikawa, 2012, Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export, Proc. Natl. Acad. Sci. USA, 109, 4152, 10.1073/pnas.1119338109 · DOI · Paper page
- Elas, 2008, Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy, Free Radic. Biol. Med., 45, 321, 10.1016/j.freeradbiomed.2008.04.016 · DOI
- Galvano, 2010, Oxidative stress in normal-weight obese syndrome, Obesity, 18, 2125, 10.1038/oby.2010.50 · DOI
- Grattagliano, 2008, Oxidative stress-induced risk factors associated with the metabolic syndrome: A unifying hypothesis, J. Nutr. Biochem., 19, 491, 10.1016/j.jnutbio.2007.06.011 · DOI · Paper page
- Itabe, 2011, The Dynamics of Oxidized LDL during Atherogenesis, J. Lipids, 2011, 418313, 10.1155/2011/418313 · DOI
- Fantuzzi, 2007, Adipose tissue and atherosclerosis: Exploring the connection, Arterioscler. Thromb. Vasc. Biol., 27, 996, 10.1161/ATVBAHA.106.131755 · DOI · Paper page
- Larque, 2010, Oxidized LDL and its correlation with lipid profile and oxidative stress biomarkers in young healthy Spanish subjects, J. Physiol. Biochem., 66, 221, 10.1007/s13105-010-0028-4 · DOI
- Carraro, 2014, Intake of red wine in different meals modulates oxidized LDL level, oxidative and inflammatory gene expression in healthy people: A randomized crossover trial, Oxid. Med. Cell. Longev., 2014, 681318
- Ponikowski, 2015, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger, Eur. Heart J., 36, 657, 10.1093/eurheartj/ehu385 · DOI · Paper page
- Valenti, 2010, HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease, Gastroenterology, 138, 905, 10.1053/j.gastro.2009.11.013 · DOI · Paper page
- Pietrangelo, 1996, Metals, oxidative stress, and hepatic fibrogenesis, Semin. Liver Dis., 16, 13, 10.1055/s-2007-1007215 · DOI · Paper page
- Pietrangelo, 2015, Pathogens, Metabolic Adaptation, and Human Diseases—An Iron-Thrifty Genetic Model, Gastroenterology, 149, 834, 10.1053/j.gastro.2015.08.003 · DOI
- Ikeda, 2016, Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway, J. Trace Elem. Med. Biol., 35, 66, 10.1016/j.jtemb.2016.01.011 · DOI · Paper page
- Kramer, 2017, Extensive Type II Muscle Fiber Atrophy in Elderly Female Hip Fracture Patients, J. Gerontol. A Biol. Sci. Med. Sci., 72, 1369, 10.1093/gerona/glw253 · DOI
- Sayed, 2016, Identification of morphological markers of sarcopenia at early stage of aging in skeletal muscle of mice, Exp. Gerontol., 83, 22, 10.1016/j.exger.2016.07.007 · DOI
- Altun, 2007, Iron load and redox stress in skeletal muscle of aged rats, Muscle Nerve, 36, 223, 10.1002/mus.20808 · DOI · Paper page
- Xu, J., Knutson, M.D., Carter, C.S., and Leeuwenburgh, C. (2008). Iron accumulation with age, oxidative stress and functional decline. PLoS ONE, 3. · DOI · Paper page
- Kasztura, 2017, Both iron excess and iron depletion impair viability of rat H9C2 cardiomyocytes and L6G8C5 myocytes, Kardiol. Pol., 75, 267, 10.5603/KP.a2016.0155 · DOI
- Ding, 2021, Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis, J. Cachexia Sarcopenia Muscle, 12, 746, 10.1002/jcsm.12700 · DOI · Paper page
- Perna, 2017, Sarcopenia and sarcopenic obesity in comparison: Prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly, Aging Clin. Exp. Res., 29, 1249, 10.1007/s40520-016-0701-8 · DOI
- Kim, T.H., Hwang, H.J., and Kim, S.H. (2014). Relationship between Serum Ferritin Levels and Sarcopenia in Korean Females Aged 60 Years and Older Using the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008–2009. PLoS ONE, 9. · DOI
- Xu, 2012, Long-term perturbation of muscle iron homeostasis following hindlimb suspension in old rats is associated with high levels of oxidative stress and impaired recovery from atrophy, Exp. Gerontol., 47, 100, 10.1016/j.exger.2011.10.011 · DOI · Paper page
- Argiles, 2014, Cachexia: A problem of energetic inefficiency, J. Cachexia Sarcopenia Muscle, 5, 279, 10.1007/s13539-014-0154-x · DOI · Paper page
- Borkowska, 2019, Iron Metabolism of the Skeletal Muscle and Neurodegeneration, Front. Neurosci., 13, 165, 10.3389/fnins.2019.00165 · DOI
- Reardon, 2009, Iron injections in mice increase skeletal muscle iron content, induce oxidative stress and reduce exercise performance, Exp. Physiol., 94, 720, 10.1113/expphysiol.2008.046045 · DOI
- Kobak, 2018, Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions, Int. J. Mol. Med., 41, 2678
- Zhang, 2019, Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting, J. Cachexia Sarcopenia Muscle, 10, 557, 10.1002/jcsm.12414 · DOI
- Ikeda, 2022, The role of iron in obesity and diabetes, J. Med. Investig., 69, 1, 10.2152/jmi.69.1 · DOI
- Yan, 2018, Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice, Endocr. Connect., 7, 604, 10.1530/EC-18-0054 · DOI · Paper page
- Orr, 2014, Obesity alters adipose tissue macrophage iron content and tissue iron distribution, Diabetes, 63, 421, 10.2337/db13-0213 · DOI · Paper page
- Tajima, 2012, Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice, Am. J. Physiol. Endocrinol. Metab., 302, E77, 10.1152/ajpendo.00033.2011 · DOI · Paper page
- Xue, 2016, Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice, Ann. N. Y. Acad. Sci., 1375, 52, 10.1111/nyas.13174 · DOI
- Blesia, V., Patel, V.B., Al-Obaidi, H., Renshaw, D., and Zariwala, M.G. (2021). Excessive Iron Induces Oxidative Stress Promoting Cellular Perturbations and Insulin Secretory Dysfunction in MIN6 Beta Cells. Cells, 10. · DOI
- Qiu, 2022, The role of iron metabolism in chronic diseases related to obesity, Mol. Med., 28, 130, 10.1186/s10020-022-00558-6 · DOI
- Ortega, 2014, Fine-tuned iron availability is essential to achieve optimal adipocyte differentiation and mitochondrial biogenesis, Diabetologia, 57, 1957, 10.1007/s00125-014-3298-5 · DOI
- 2012, Mitochondria and endocrine function of adipose tissue, Best Pract. Res. Clin. Endocrinol. Metab., 26, 791, 10.1016/j.beem.2012.06.002 · DOI
- Rumberger, 2004, Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes, Diabetes, 53, 2535, 10.2337/diabetes.53.10.2535 · DOI · Paper page
- Rajpathak, 2009, Biomarkers of body iron stores and risk of developing type 2 diabetes, Diabetes Obes. Metab., 11, 472, 10.1111/j.1463-1326.2008.00985.x · DOI · Paper page
- Liu, 2018, Renal tubule injury: A driving force toward chronic kidney disease, Kidney Int., 93, 568, 10.1016/j.kint.2017.09.033 · DOI · Paper page
- Baliga, 1993, Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys, Biochem. J., 291, 901, 10.1042/bj2910901 · DOI · Paper page
- Baliga, 1998, In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity, Kidney Int., 53, 394, 10.1046/j.1523-1755.1998.00767.x · DOI · Paper page
- Wish, 2018, Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?, Am. J. Nephrol., 47, 72, 10.1159/000486968 · DOI
- Wetzels, 2020, The multifaceted role of iron in renal health and disease, Nat. Rev. Nephrol., 16, 77, 10.1038/s41581-019-0197-5 · DOI · Paper page
- ElAlfy, 2018, Renal iron deposition by magnetic resonance imaging in pediatric beta-thalassemia major patients: Relation to renal biomarkers, total body iron and chelation therapy, Eur. J. Radiol., 103, 65, 10.1016/j.ejrad.2018.04.007 · DOI
- Tang, 2020, Ferroptosis and kidney diseases, Int. Urol. Nephrol., 52, 497, 10.1007/s11255-019-02335-7 · DOI
- Dixon, 2012, Ferroptosis: An iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 · DOI · Paper page
- Wang, 2020, Mitochondria regulation in ferroptosis, Eur. J. Cell Biol., 99, 151058, 10.1016/j.ejcb.2019.151058 · DOI · Paper page
- Deng, 2020, Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1/GPX4 Assisted ALI-Induced Nephrotoxicity, Front. Pharmacol., 11, 624529, 10.3389/fphar.2020.624529 · DOI
- Bhat, 2015, Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight, Biomed. Pharmacother., 74, 101, 10.1016/j.biopha.2015.07.025 · DOI · Paper page
- Moos, 2004, The metabolism of neuronal iron and its pathogenic role in neurological disease: Review, Ann. N. Y. Acad. Sci., 1012, 14, 10.1196/annals.1306.002 · DOI · Paper page
- Islam, 2017, Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders, Neurol. Res., 39, 73, 10.1080/01616412.2016.1251711 · DOI · Paper page
- Federico, 2012, Mitochondria, oxidative stress and neurodegeneration, J. Neurol. Sci., 322, 254, 10.1016/j.jns.2012.05.030 · DOI · Paper page
- Ward, 2015, Ageing, neuroinflammation and neurodegeneration, Front. Biosci. Schol. Ed., 7, 189, 10.2741/s433 · DOI · Paper page
- Posadas, 2018, Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress, Antioxid. Redox Signal., 28, 1669, 10.1089/ars.2017.7272 · DOI · Paper page
- Quintana, 2004, Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin, J. Struct. Biol., 147, 166, 10.1016/j.jsb.2004.03.001 · DOI · Paper page
- Cheng, 2022, Mitochondrial iron metabolism and neurodegenerative diseases, Neurotoxicology, 88, 88, 10.1016/j.neuro.2021.11.003 · DOI
- Worwood, 1982, Ferritin in human tissues and serum, Clin. Haematol., 11, 275, 10.1016/S0308-2261(21)00338-6 · DOI
- Powell, 1975, Human isoferritins: Organ specific iron and apoferritin distribution, Br. J. Haematol., 30, 47, 10.1111/j.1365-2141.1975.tb00516.x · DOI
- Zhang, 2021, New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases, Mol. Neurobiol., 58, 2812, 10.1007/s12035-020-02277-7 · DOI · Paper page
- Bossoni, 2017, Human-brain ferritin studied by muon spin rotation: A pilot study, J. Phys. Condens. Matter, 29, 415801, 10.1088/1361-648X/aa80b3 · DOI
- Strbak, 2020, Quantitative Analysis of Magnetoferritin-Induced Relaxivity Enhancement in MRI, Acta Phys. Pol. A, 137, 720, 10.12693/APhysPolA.137.720 · DOI
- 2014, Early onset Alzheimer’s disease and oxidative stress, Oxid. Med. Cell. Longev., 2014, 375968
- Huang, 1999, The A beta peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry, 38, 7609, 10.1021/bi990438f · DOI · Paper page
- Pratico, 2004, 12/15-lipoxygenase is increased in Alzheimer’s disease: Possible involvement in brain oxidative stress, Am. J. Pathol., 164, 1655, 10.1016/S0002-9440(10)63724-8 · DOI · Paper page
- Yang, 2010, Amelioration of the Alzheimer’s disease phenotype by absence of 12/15-lipoxygenase, Biol. Psychiatry, 68, 922, 10.1016/j.biopsych.2010.04.010 · DOI
- Feeney, 2008, Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices, Brain Res., 1198, 1, 10.1016/j.brainres.2007.12.049 · DOI
- Rubinsztein, 2003, Huntington’s disease: Molecular basis of neurodegeneration, Expert Rev. Mol. Med., 5, 1, 10.1017/S1462399403006549 · DOI · Paper page
- Shi, 2010, Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: Implication for neuroprotection in Parkinson’s disease, Antioxid. Redox Signal., 13, 783, 10.1089/ars.2009.3018 · DOI · Paper page
- Guan, 2017, Mitochondrial ferritin protects SH-SY5Y cells against H2O2-induced oxidative stress and modulates alpha-synuclein expression, Exp. Neurol., 291, 51, 10.1016/j.expneurol.2017.02.001 · DOI
- Mizuno, 1995, Role of mitochondria in the etiology and pathogenesis of Parkinson’s disease, Biochim. Biophys. Acta, 1271, 265, 10.1016/0925-4439(95)00038-6 · DOI · Paper page
- Munoz, 2016, Parkinson’s Disease: The Mitochondria-Iron Link, Park. Dis., 2016, 7049108
- Carroll, 2011, Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson’s disease, Neurochem. Int., 59, 73, 10.1016/j.neuint.2011.05.006 · DOI
- Mena, 2015, The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death, Biochem. Biophys. Res. Commun., 463, 787, 10.1016/j.bbrc.2015.06.014 · DOI
- Ludwig, 2015, Iron metabolism and iron supplementation in cancer patients, Wien. Klin. Wochenschr., 127, 907, 10.1007/s00508-015-0842-3 · DOI
- Bystrom, 2015, Cancer cells with irons in the fire, Free Radic. Biol. Med., 79, 337, 10.1016/j.freeradbiomed.2014.04.035 · DOI · Paper page
- Biasiotto, 2020, The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against SARS-CoV-2 infection (COVID-19): A role for iron homeostasis?, Pharmacol. Res., 158, 104904, 10.1016/j.phrs.2020.104904 · DOI
- Cerqueira, 2007, Ribonucleotide reductase: A critical enzyme for cancer chemotherapy and antiviral agents, Recent Pat. Anticancer Drug Discov., 2, 11, 10.2174/157489207779561408 · DOI
- Kong, 2022, BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance, Redox Biol., 54, 102356, 10.1016/j.redox.2022.102356 · DOI
- Hooda, J., Cadinu, D., Alam, M.M., Shah, A., Cao, T.M., Sullivan, L.A., Brekken, R., and Zhang, L. (2013). Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells. PLoS ONE, 8. · DOI · Paper page
- Basuli, 2017, Iron addiction: A novel therapeutic target in ovarian cancer, Oncogene, 36, 4089, 10.1038/onc.2017.11 · DOI · Paper page
- Zhang, 2020, Pan-cancer analysis of iron metabolic landscape across the Cancer Genome Atlas, J. Cell Physiol., 235, 1013, 10.1002/jcp.29017 · DOI
- Xue, 2015, Decreased expression of ferroportin in prostate cancer, Oncol. Lett., 10, 913, 10.3892/ol.2015.3363 · DOI
- Pinnix, 2010, Ferroportin and iron regulation in breast cancer progression and prognosis, Sci. Transl. Med., 2, 43ra56, 10.1126/scitranslmed.3001127 · DOI · Paper page
- Guo, 2015, An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis, Acta Biochim. Biophys. Sin., 47, 703, 10.1093/abbs/gmv063 · DOI · Paper page
- Shan, 2018, Suppression of ferroportin expression by cadmium stimulates proliferation, EMT, and migration in triple-negative breast cancer cells, Toxicol. Appl. Pharmacol., 356, 36, 10.1016/j.taap.2018.07.017 · DOI
- Hung, 2013, Mitoferrin-2-dependent mitochondrial iron uptake sensitizes human head and neck squamous carcinoma cells to photodynamic therapy, J. Biol. Chem., 288, 677, 10.1074/jbc.M112.422667 · DOI · Paper page
- Lui, 2015, Targeting cancer by binding iron: Dissecting cellular signaling pathways, Oncotarget, 6, 18748, 10.18632/oncotarget.4349 · DOI · Paper page
- Estrov, 1987, In vitro and in vivo effects of deferoxamine in neonatal acute leukemia, Blood, 69, 757, 10.1182/blood.V69.3.757.757 · DOI · Paper page
- Abdelaal, 2021, Reversing oncogenic transformation with iron chelation, Oncotarget, 12, 106, 10.18632/oncotarget.27866 · DOI
- Lesjak, 2019, Quercetin inhibits intestinal non-haem iron absorption by regulating iron metabolism genes in the tissues, Eur. J. Nutr., 58, 743, 10.1007/s00394-018-1680-7 · DOI
- Chen, 2020, CN128: A New Orally Active Hydroxypyridinone Iron Chelator, J. Med. Chem., 63, 4215, 10.1021/acs.jmedchem.0c00137 · DOI
Cited by
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Chomyk, A., Kucinski, R., Kim, J., Christie, E., Cyncynatus, K., Gossman, Z., Chen, Z., Richardson, B., Cameron, M., Turner, T., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26877 · Cited by 9
Candida albicans enhances iron uptake to maintain fluconazole resistance
Sharma, R., Nahar, A., & Puri, S. (2025) · Infection and Immunity · doi:10.1128/iai.00002-25 · Cited by 8
Metadata
- Authors
- Duan, G., Li, J., Duan, Y., Zheng, C., Guo, Q., Li, F., Zheng, J., Yu, J., Zhang, P., Wan, M., & Long, C.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2022-12-21
- Volume
- 28
- Issue
- 1
- Pages
- 29
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W4313502820
- Cited by
- 69
- References
- 48
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Natural Science Foundation of Hunan Province (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
- Changsha Natural Science Funds for Distinguished Young Scholar (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
- Science and Technology Innovation Program of Hunan Province (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
- National Key Research and Development Programs of China (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
- China Agriculture Research System of MOF and MARA (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.